0.3285 -0.0264(-7.4074%)09/16/2024
Aptevo Therapeutics Inc (APVO)
Aptevo Therapeutics Inc (APVO)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Aptevo Therapeutics (APVO) Upgraded to Buy: Here's What You Should Know | 08/15 13:06 | zacks.com |
| Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated | 08/13 08:05 | accesswire.com |
| Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update | 08/08 08:05 | accesswire.com |
| Aptevo Therapeutics Announces Closing of $2.75 Million Offering | 07/01 16:20 | accesswire.com |
| Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules | 06/28 09:20 | accesswire.com |
| Aptevo Participating in the BIO International Convention | 06/03 08:05 | accesswire.com |
| Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E | 05/28 09:21 | zacks.com |
| Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA | 05/14 08:05 | accesswire.com |
| Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update | 05/08 08:05 | accesswire.com |